(Q34380853)

1 August 2017

1 reference

title

Behavioural effects of anti-epileptic drugs (English)

1 reference

1 August 2017

Gregory Stores

1

0 references

G. Stores

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A241674

27 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=241674

27 January 2023

publication date

1 October 1975

1 reference

full work available at URL

1 August 2017

12 November 2008

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1469-8749.1975.tb03536.x

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1469-8749.1975.tb03536.x/fullpdf

27 January 2023

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Developmental Medicine and Child Neurology

27 January 2023

published in

1 reference

1 August 2017

volume

17

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

647-658

1 reference

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.1975.TB03536.X

Pseudodegenerative Disease Due to Diphenylhydantoin Intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.1975.TB03536.X

Antianxiety Drugs and Human Performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.1975.TB03536.X

The effect of sulthiame on disturbed behaviour in mentally subnormal patients.

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Mental deterioration in epileptic children

27 January 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Chronic drug intoxication causing pseudoretardation in a young child

27 January 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy

27 January 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Coarse features in epilepsy as a consequence of anticonvulsant therapy. Report of cases in two pairs of identical twins

27 January 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Sulthiame: evaluation as an anticonvulsant

27 January 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

The Relation of Parental Attitudes to Academic and Social Achievement in Epileptic Children

27 January 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Unusual brain syndrome seen with diphenylhydantoin and pentobarbital.

27 January 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Behavioral parameters and drug effects. A study of a hyperkinetic epileptic child

27 January 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Perceptual-Motor Behaviour in Relation to Blood Phenobarbitone Level: A Preliminary Report

27 January 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Acute effects of diphenylhydantoin in relation to plasma levels: Behavioural and psychophysiological studies

27 January 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Untoward effects of anticonvulsants

27 January 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Treatment of epilepsy with diphenylhydantoin sodium (dilantin sodium)

27 January 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Choreo-athetosis and encephalopathy induced by phenytoin

27 January 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

27 January 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

The use of sulthiame with disturbed mentally subnormal patients.

27 January 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

The hyperkinetic syndrome in epileptic children

27 January 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report

27 January 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Drug interactions in epilepsy

27 January 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Psychometric study of children with learning problems and 14-6 positive spike EEG patterns, treated with ethosuximide (Zarontin) and placebo

27 January 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

Diphenylhydantoin and phenobarbital in the relief of psychoneurotic symptoms. A controlled comparison

27 January 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1469-8749.1975.TB03536.X

27 January 2023

Identifiers

0 references

1 reference